Quickstart Highlights

Cardiogen is a synthetic cardiovascular bioregulator tetrapeptide (AEDR: Ala‑Glu‑Asp‑Arg) studied for its cellular repair and cardioprotective properties^[1][2]. Preclinical research demonstrates Cardiogen enters cells and modulates fundamental survival pathways, supporting cytoskeletal integrity and reducing apoptosis in stressed cardiac tissue while paradoxically encouraging apoptosis in abnormal cells^[3][4]. This educational protocol presents a once‑daily subcutaneous approach for research applications.

• Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
• Typical daily range: 200–500 mcg once daily (gradual titration over 8–16 weeks).
• Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Protocol Overview

Concise summary of the once‑daily regimen.

• Goal: Support cellular repair mechanisms and cardiovascular tissue resilience in research models^[1][2].
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 200–500 mcg daily with gradual titration.
• Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach based on preclinical research^[5].

• Start: 200 mcg daily for 2 weeks; increase by ~100 mcg every 1–2 weeks.
• Target: 400–500 mcg daily by Weeks 5–12.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites daily.

Storage Instructions

Proper storage preserves peptide quality^[12].

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) for up to 2–4 weeks with bacteriostatic water; avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• Consider 30‑ or 50‑unit insulin syringes for improved precision with small volumes.

How This Works

Cardiogen functions as a gene expression bioregulator operating at the cellular and nuclear level^[3]. Research demonstrates it upregulates structural proteins including actin, tubulin, vimentin, and nuclear lamins, thereby supporting cytoskeletal integrity and nuclear matrix function^[3]. This mechanism promotes cell repair and reduces programmed cell death in stressed or damaged tissue^[1][2]. Notably, Cardiogen appears to suppress overactive p53‑mediated apoptosis signals under stress conditions, allowing healthy cells to survive injury while paradoxically encouraging apoptosis in abnormal or cancerous cells^[4]. In rodent cardiac studies, daily Cardiogen administration reduced post‑myocardial infarction mortality approximately threefold, preserved cardiac tissue architecture, and maintained higher glycogen reserves in heart muscle cells^[1][2]. The peptide enhances metabolic resilience by improving mitochondrial integrity and preserving energy stores during stress^[2].

Potential Benefits & Side Effects

Observations from preclinical research models.

• Demonstrated cardioprotective effects in rodent myocardial infarction models, reducing mortality and necrotic tissue formation^[1][2].
• Stimulates cardiomyocyte and fibroblast proliferation while decreasing pro‑apoptotic factors, potentially reducing pathological fibrosis^[3].
• Shows selective dual action: protects healthy cells while promoting apoptosis in tumor cells (demonstrated in M‑1 sarcoma models)^[4].
• Preserves metabolic function in cardiac tissue, maintaining glycogen stores and mitochondrial integrity during stress^[2].
• No human clinical data available; all evidence derives from laboratory and animal research^[5].
• Generally well tolerated in preclinical models; occasional mild injection‑site reactions possible with subcutaneous administration.

Lifestyle Factors

Complementary strategies for research protocols.

• Maintain consistent timing of daily injections to establish stable plasma levels.
• Document any observable effects or changes systematically throughout the research period.
• Ensure proper cold‑chain maintenance for all peptide storage to preserve potency.
• Consider splitting into sterile aliquots if extended use periods require multiple vial openings.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources^[13][14].

• Clean the vial stopper and skin with alcohol; allow to dry completely before proceeding.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[15][16].
• Do not aspirate for subcutaneous injections; inject slowly and steadily^[15].
• Rotate sites systematically (abdomen at least 2 inches from navel, outer thighs, upper arms) to avoid lipohypertrophy^[13][17].
• Apply gentle pressure post‑injection with clean gauze; do not rub the site.
• Dispose of used syringes immediately in a proper sharps container.

Recommended Source

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

References